YOLFTbeta
Fluicell AB

Fluicell AB

FLUI · ST · Healthcare / Biotechnology

26.20SEK-1.60 (-5.76%)

Price History

Full chart

Market Stats

Previous Close27.80
Open27.80
Day Range23.20 – 27.80
52-Week Range7.65 – 67.20
Volume9.45K
Market Cap41.21M
P/E (TTM)14.78
Forward P/E0.00
EPS2.03
Dividend Yield0.00%
Beta2.01
50-Day Avg31.02
200-Day Avg23.06

About

Fluicell AB (publ), a life science company, develops and provides clay instruments for 3D bioprinting and cell analysis and flow control on single-cell level in Sweden. The company offers BIOPEN, a powerful tool for high precision cell biology that uses open volume microfluidics; Biozone 6 that generate dose-response curves or study the effects of multiple drug compounds; and Dynaflow Resolve system, an ion channel screening platform, which allows to record various ion channel current in patch clamp recording configuration. It also provides Biopixlar, a 3D single-cell bioprinting platform that produces single cell arrays to organoids and complex tissues; Nexocyte, a platform for universal tissue production; and Biopixlar AER, a single-cell bioprinting platform that fits into a biosafety cabinet. Fluicell AB (publ) was incorporated in 2012 and is based in Mölndal, Sweden.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOMs. Carolina Trjulja
  • Employees11
  • HeadquartersFlöjelbergsgatan 8C, Mölndal, Sweden, 431 37, Sweden
  • Websitehttps://www.fluicell.com

Leadership

  • Ms. Carolina TrjuljaChief Executive Officer · b. 1984
  • Mr. Gavin D. M. JeffriesCo-Founder, CTO & Director · b. 1980
  • Mr. Joakim WahlbergChief Financial Officer · b. 1970
  • Mr. Jonas HannestadChief Marketing & Communications Officer · b. 1981

Financials

Income Statement

Currency: SEK2014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue140.27K1.42M2.63M1.05M1.23M2.49M4.63M2.60M3.25M3.34M1.86M6.00M
Growth (%)-+909.36%+86.11%-60.08%+16.54%+102.94%+86.29%-43.86%+24.94%+2.68%-44.31%+222.86%
Cost of Revenue53.05K5.26M7.59M8.49M391.00K443.00K988.00K715.00K663.00K1.60M1.59M14.69M
Gross Profit87.22K-3.85M-4.96M-7.44M835.00K2.04M3.65M1.89M2.59M1.74M3.76M-8.69M
Gross Margin62.18%-271.86%-188.16%-707.41%68.11%82.19%78.68%72.52%79.61%52.07%202.26%-144.70%
Operating Expense1.72M-18.00K-6.00K15.61M20.73M20.67M23.58M24.32M28.62M19.60M0
Operating Income-1.64M-3.85M-4.97M-7.44M-14.78M-18.68M-17.03M-21.70M-21.73M-26.88M-15.84M-8.69M
Operating Margin-1166.91%-271.86%-188.46%-706.84%-1205.38%-750.92%-367.34%-833.78%-668.32%-805.24%-852.18%-144.70%
EBITDA-1.59M-3.67M-4.84M-7.37M-14.37M-18.11M-16.42M-21.08M-20.89M-25.91M-14.99M-8.31M
EBITDA Margin-1133.58%-259.31%-183.61%-700.10%-1172.27%-728.01%-354.28%-810.07%-642.48%-776.33%-806.46%-138.54%
Net Income-1.65M-3.78M-4.95M-7.47M-14.70M-18.64M-18.15M-21.72M-21.49M-26.55M-15.51M-8.33M
Net Income Margin-1174.10%-267.23%-187.86%-710.08%-1199.02%-749.00%-391.67%-834.74%-660.94%-795.51%-834.37%-138.82%
Interest Expense--27.00K34.00K2.00K421.00K564.00K27.00K47.00K30.00K79.00K193.00K
Interest Expense % of Total Revenue--1.02%3.23%0.16%16.92%12.17%1.04%1.45%0.90%4.25%3.22%

Balance Sheet

Currency: SEK2014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets1.67M1.71M2.77M11.54M25.97M19.94M24.83M26.98M31.77M9.34M25.51M18.48M
Total Liabilities484.76K1.01M934.00K1.95M2.60M9.71M5.33M7.87M8.32M8.91M6.27M7.57M
Total Equity1.19M694.00K1.84M9.58M23.37M10.22M19.50M19.11M23.45M425.00K19.23M10.90M
Cash1.14M746.00K1.10M7.83M22.23M8.44M18.80M20.69M24.46M2.76M15.92M2.26M
Total Debt232.96K368.00K220.00K73.00K-5.00M------
Net Debt-902.92K-378.00K-879.00K-7.76M-22.23M-3.44M-18.80M-20.69M-24.46M-2.76M-15.92M-2.26M

Cash Flow

Currency: SEK2014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow---5.50M-7.83M-12.46M-17.07M-17.57M-18.64M-21.04M-27.23M-15.67M-4.95M
Investing Cash Flow---83.00K-500.00K-1.56M-812.00K-331.00K-772.00K-1.14M0-3.49M-8.67M
Financing Cash Flow--5.93M15.06M28.42M4.09M28.26M21.31M25.94M5.53M32.32M0
Capital Expenditure0083.00K500.00K1.56M812.00K331.00K772.00K1.14M03.49M4.95M
Free Cash Flow---5.58M-8.33M-14.02M-17.88M-17.90M-19.41M-22.18M-27.23M-15.67M-13.61M
Dividends Paid-----5.00M------
FCF to OCF--101.51%106.38%112.49%104.76%101.88%104.14%105.40%100.00%100.00%275.27%
Dividend Paid to FCF------27.96%------

Earnings

Report DateJun 30, 2018Sep 30, 2018Dec 31, 2018Mar 31, 2019Jun 30, 2019Sep 30, 2019Dec 31, 2019Mar 31, 2020Jun 30, 2020Sep 30, 2020Dec 31, 2020Mar 31, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023Jun 30, 2023Sep 30, 2023Jan 4, 2024May 16, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate---------------------------------
EPS Actual-38.32-34.24-46.14-40.23-44.44-41.73-55.08-32.20-29.91-33.86-29.76-32.41-35.93-28.62-31.34-26.65-37.31-13.47-26.74-17.88-22.52-18.20-0.07-0.02-4.79-0.77-1.04-1.95-2.10-2.090.072.411.65
Surprise---------------------------------
Timing----------------------After-hoursAfter-hours---------

Key Statistics & Ratios

Market Cap41.21M
Enterprise Value43.59M
Trailing P/E14.78
Forward P/E0.00
Price / Sales2.23
Price / Book2.53
EPS2.03
Book Value11.99
Revenue (TTM)18.44M
Gross Profit (TTM)16.03M
EBITDA2.94M
Profit Margin15.19%
Operating Margin30.77%
Return on Equity18.58%
Return on Assets7.42%
Shares Outstanding1.37M
Shares Float1.11M
Beta2.01
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Stock Splits

  • Mar 26, 20251:350
  • Jan 10, 20243754:873
  • Oct 4, 2022143:128